BCIM
MRNA icon

British Columbia Investment Management’s Moderna MRNA Stock Holding History

British Columbia Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-62,538
Closed -$1.77M – 700
2025
Q1 		$1.77M Sell
62,538
-16
-0% -$568 0.01% 644
2024
Q4 		$2.6M Buy
62,554
+8,212
+15% +$392K 0.02% 584
2024
Q3 		$3.63M Sell
54,342
-7,985
-13% -$733K 0.02% 451
2024
Q2 		$7.4M Buy
62,327
+23,633
+61% +$2.99M 0.04% 298
2024
Q1 		$4.12M Buy
38,694
+1,454
+4% +$147K 0.03% 373
2023
Q4 		$3.7M Buy
37,240
+7,772
+26% +$654K 0.03% 376
2023
Q3 		$3.04M Sell
29,468
-99
-0.3% -$11K 0.03% 366
2023
Q2 		$3.59M Buy
29,567
+480
+2% +$64K 0.03% 336
2023
Q1 		$4.47M Sell
29,087
-366
-1% -$60.4K 0.05% 281
2022
Q4 		$5.29M Sell
29,453
-4,061
-12% -$664K 0.06% 246
2022
Q3 		$3.96M Sell
33,514
-6,219
-16% -$944K 0.04% 300
2022
Q2 		$5.68M Sell
39,733
-13,469
-25% -$1.93M 0.05% 272
2022
Q1 		$9.16M Sell
53,202
-7,168
-12% -$1.21M 0.06% 263
2021
Q4 		$15.3M Sell
60,370
-2,743
-4% -$802K 0.09% 204
2021
Q3 		$24.3M Buy
63,113
+4,453
+8% +$1.64M 0.14% 118
2021
Q2 		$13.8M Buy
58,660
+13,292
+29% +$2.38M 0.08% 220
2021
Q1 		$5.94M Sell
45,368
-1,380
-3% -$200K 0.04% 344
2020
Q4 		$4.88M Sell
46,748
-452
-1% -$45.7K 0.03% 392
2020
Q3 		$3.34M Buy
47,200
+3,584
+8% +$250K 0.03% 439
2020
Q2 		$2.8M Buy
+43,616
New +$2.39M 0.03% 447

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

British Columbia Investment Management's MRNA Position: Q2 2025 in Review

British Columbia Investment Management sold out of Moderna (MRNA) in Q2 2025, closing a stake of 62,538 shares — an estimated $1.77M sold.

British Columbia Investment Management first reported a position in MRNA in Q2 2020 and held it in 20 quarters. The position peaked at $24.3M in Q3 2021. 675 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • British Columbia Investment Management reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • British Columbia Investment Management sold 62,538 Moderna shares in Q2 2025, an estimated $1.77M.
  • British Columbia Investment Management first reported a position in Moderna in Q2 2020 and held it in 20 quarters.
  • British Columbia Investment Management's Moderna position peaked at $24.3M in Q3 2021.
  • 675 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on British Columbia Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.